Association between heme oxygenase-1 gene promoter polymorphisms and metabolic syndrome in Iranians

Molecular Biology Reports

Volumn 39, Issue 3, 2012, Pages 3355-3360

  Javanmard, Shaghayegh Haghjooy ^a   Keyhanian, Kiandokht ^a   Loghmani, Parisa ^a   Abbas Samety, Amir ^a   Haghdoost, Faraidoon ^a   Rafiei, Laleh ^a   Talaei, Mohammad ^b   Asgari, Sedigheh ^a,b   Jazi, Mohammad Hashemi ^a,c   Sarrafzadegan, Nizal ^b,c  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Atherosclerosis; Gene polymorphism; GT repeat; HO 1; Metabolic syndrome; Promoter polymorphism

Indexed keywords

BILIRUBIN; FERRITIN; HEME OXYGENASE 1; IRON;

ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; DINUCLEOTIDE REPEAT; DNA EXTRACTION; ETHNICITY; FERRITIN BLOOD LEVEL; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPING TECHNIQUE; HO 1 GENE; HUMAN; IRAN; IRANIAN; IRON BLOOD LEVEL; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; POLYMERASE CHAIN REACTION; PROMOTER REGION;

ANALYSIS OF VARIANCE; BILIRUBIN; CASE-CONTROL STUDIES; COHORT STUDIES; DINUCLEOTIDE REPEATS; DNA PRIMERS; FERRITINS; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEME OXYGENASE-1; HUMANS; IRAN; IRON; METABOLIC SYNDROME X; ODDS RATIO; PROMOTER REGIONS, GENETIC; RISK FACTORS;

EID: 84863855738     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1105-7     Document Type: Article

References (23)

1. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24(4):683-689
2. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. J Am Med Assoc 288(21):2709-2716
3. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114(12):1752-1761. doi:10.1172/JCI200319246
4. Helal O, Defoort C, Robert S, Marin C, Lesavre N, Lopez-Miranda J, Riserus U, Basu S, Lovegrove J, McMonagle J, Roche HM, Dignat-George F, Lairon D (2010) Increased levels of microparticles originating from endothelial cells, platelets and erythrocytes in subjects with metabolic syndrome: relationship with oxidative stress. Nutr Metab Cardiovasc Dis. doi:10.1016/ j.numecd.2010.01.004
5. Willis D, Moore AR, Frederick R, Willoughby DA (1996) Heme oxygenase: a novel target for the modulation of the inflammatory response. Nat Med 2(1):87-90
6. Paine A, Eiz-Vesper B, Blasczyk R, Immenschuh S (2010) Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochem Pharmacol 80(12):1895-1903. doi:10.1016/ j.bcp.2010.07.014
7. Dong HK, Burgess AP, Li M, Tsenovoy PL, Addabbo F, McClung JA, Puri N, Abraham NG (2008) Heme oxygenase-mediated increases in adiponectin decrease fat content and inflammatory cytokines tumor necrosis factor-a and interleukin-6 in Zucker rats and reduce adipogenesis in human mesenchymal stem cells. J Pharmacol Exp Ther 325(3):833-840
8. Johnson FK, Johnson RA, Durante W, Jackson KE, Stevenson BK, Peyton KJ (2006) Metabolic syndrome increases endogenous carbon monoxide production to promote hypertension and endothelial dysfunction in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 290(3):R601-R608. doi:10.1152/ajpregu. 00308.2005
9. L'Abbate A, Neglia D, Vecoli C, Novelli M, Ottaviano V, Baldi S, Barsacchi R, Paolicchi A, Masiello P, Drummond GS, McClung JA, Abraham NG (2007) Beneficial effect of heme oxygenase-1 expression on myocardial ischemia-reperfusion involves an increase in adiponectin in mildly diabetic rats. Am J Physiol Heart Circ Physiol 293(6):H3532-H3541. doi:10.1152/ ajpheart.00826.2007
10. Ono K, Mannami T, Iwai N (2003) Association of a promoter variant of the haeme oxygenase-1 gene with hypertension in women. J Hypertens 21(8):1497-1503
11. Ono K, Goto Y, Takagi S, Baba S, Tago N, Nonogi H, Iwai N (2004) A promoter variant of the heme oxygenase-1 gene may reduce the incidence of ischemic heart disease in Japanese. Atherosclerosis 173(2):313-317. doi:10.1016/j.atherosclerosis. 2003.11.021
12. Yamada N, Yamaya M, Okinaga S, Nakayama K, Sekizawa K, Shibahara S, Sasaki H (2000) Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet 66(1):187-195. doi:10.1086/ 302729
13. Hirai H, Kubo H, Yamaya M, Nakayama K, Numasaki M, Kobayashi S, Suzuki S, Shibahara S, Sasaki H (2003) Microsatellite polymorphism in heme oxygenase-1 gene promoter is associated with susceptibility to oxidant-induced apoptosis in lymphoblastoid cell lines. Blood 102(5):1619-1621
14. Naylor LH, Clark EM (1990) d(TG)(n)d(CA)(n) sequences upstream of the rat prolactin gene form Z-DNA and inhibit gene transcription. Nucleic Acids Res 18(6):1595-1601
15. Kimpara T, Takeda A, Watanabe K, Itoyama Y, Ikawa S, Watanabe M, Arai H, Sasaki H, Higuchi S, Okita N, Takase S, Saito H, Takahashi K, Shibahara S (1997) Microsatellite polymorphism in the human heme oxygenase-1 gene promoter and its application in association studies with Alzheimer and Parkinson disease. Hum Genet 100(1):145-147
16. Kaneda H, Ohno M, Taguchi J, Togo M, Hashimoto H, Ogasawara K, Aizawa T, Ishizaka N, Nagai R (2002) Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors. Arterioscler Thromb Vasc Biol 22(10):1680-1685
17. Chen YH, Lin SJ, Lin MW, Tsai HL, Kuo SS, Chen JW, Charng MJ, Wu TC, Chen LC, Ding YA, Pan WH, Jou YS, Chau LY (2002) Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Hum Genet 111(1):1-8. doi: 10.1007/s00439-002-0769-4
18. Sarrafzadegan N, Talaei M, Sadeghi M, Kelishadi R, Oveisgharan S, Mohammadifard N, Sajjadieh AR, Kabiri P, Marshall T, Thomas GN, Tavasoli A (2010) The Isfahan cohort study: Rationale, methods and main findings. J Hum Hypertens. doi: 10.1038/jhh.2010.99
19. Talaei M, Sadeghi M, Marshall T, Thomas GN, Kabiri P, Hoseini S, Sarrafzadegan N (2010) Impact of metabolic syndrome on ischemic heart disease-a prospective cohort study in an Iranian adult population: Isfahan cohort study. Nutr Metab Cardiovasc Dis. doi:10.1016/j.numecd.2010.08.003
20. Sarraf-Zadegan N, Sadri G, Malek Afzali H, Baghaei M, Mohammadi Fard N, Shahrokhi S, Tolooie H, Poormoghaddas M, Sadeghi M, Tavassoli A, Rafiei M, Kelishadi R, Rabiei K, Bashardoost N, Boshtam M, Asgary S, Naderi G, Changiz T, Yousefie A (2003) Isfahan Healthy Heart Programme: a comprehensive integrated community-based programme for cardiovascular disease prevention and control. Design, methods and initial experience. Acta Cardiol 58(4):309-320
21. Miettola J, Niskanen LK, Viinamaki H, Kumpusalo E (2008) Metabolic syndrome is associated with self-perceived depression. Scand J Prim Health Care 26(4):203-210
22. Hosseini M, Haghjooy Javanmard S, Nematbakhsh M (2010) Late treatment with L-arginine increases 8-isoprostaglandin F2 and oxidized LDL in hypercholesterolemic rabbit. ARYA Atherosclerosis 5(4):1-7
23. Chen YH, Chau LY, Lin MW, Chen LC, Yo MH, Chen JW, Lin SJ (2004) Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with angiographic restenosis after coronary stenting. Eur Heart J 25(1):39-47. doi:10.1016/j.ehj. 2003.10.009